Strut Health Pricing Analysis & Total Cost

What Strut Health Sells and How It Prices Each Category

Strut Health operates as a direct-to-consumer telehealth platform that pairs asynchronous physician consultations with compounded prescription medications shipped to the patient's door. The company does not charge a separate consultation fee. Instead, the cost of the provider visit is folded into the monthly subscription.

The platform organizes its offerings into three primary verticals: men's hair loss, erectile dysfunction, and skincare. Hair loss products typically feature compounded topical solutions combining finasteride with minoxidil (and sometimes tretinoin or dutasteride). Monthly pricing for these formulas ranges from $35 to $55. ED products span oral medications like compounded sildenafil and tadalafil, with monthly costs between $45 and $95 depending on the molecule, strength, and quantity. Skincare products, primarily compounded tretinoin-based creams, fall between $30 and $50 per month.

A 2022 JAMA Dermatology study (N=3,305) confirmed that oral finasteride 1 mg daily reduced hair loss progression in 83.5% of men at 12 months, establishing the pharmacological rationale behind Strut's most popular product line [1]. The active ingredients are well studied. The question is whether the compounded delivery format and telehealth convenience justify the price premium over retail generics.

The Real Cost of Hair Loss Treatment Through Strut

For a man starting Strut Health's topical finasteride-minoxidil combination, the out-of-pocket commitment is roughly $45 per month, or $540 per year. That buys a compounded preparation applied once daily.

Compare that to purchasing the components separately. Generic oral finasteride 1 mg costs $3 to $15 per month at most retail pharmacies using a GoodRx discount [2]. Over-the-counter minoxidil 5% foam (brand name Rogaine or generic) runs $20 to $35 for a three-month supply at major retailers. Combined annual cost for both: approximately $116 to $300. Strut's version costs 1.8 to 4.7 times more.

The clinical case for topical finasteride rests on reducing systemic exposure. A randomized trial published in the Journal of the American Academy of Dermatology found that topical finasteride 0.25% reduced scalp dihydrotestosterone (DHT) by a comparable margin to oral finasteride while producing lower serum DHT suppression (34.5% vs. 55.6%) [3]. For men concerned about sexual side effects, which affected 1.4% of patients in the original Prostate Cancer Prevention Trial, topical application offers a pharmacokinetic advantage [4]. Whether that advantage is worth $240 to $424 per year in added cost is a clinical and personal judgment.

Strut also offers dutasteride-containing topical compounds at higher price points, around $55 per month. Dutasteride inhibits both type I and type II 5-alpha reductase, and a 2019 systematic review in the Journal of the American Academy of Dermatology found it produced greater hair count increases than finasteride at 24 weeks [5]. The compounded topical format for dutasteride is not available as an FDA-approved product, which makes Strut one of the few ways to access it without an off-label oral prescription.

ED Medication Pricing: Strut vs. the Generic Market

Strut Health's erectile dysfunction offerings include compounded sildenafil, tadalafil, and combination formulations. Monthly pricing ranges from $45 for basic sildenafil to $95 for higher-dose tadalafil or multi-ingredient compounds.

This is where the price gap becomes most visible. Generic sildenafil 20 mg tablets (often prescribed as 5 tablets equaling 100 mg) cost as little as $0.50 to $2.00 per dose at retail pharmacies with a GoodRx coupon. Generic tadalafil 5 mg daily runs $8 to $25 per month. A man filling generic tadalafil 5 mg daily at a retail pharmacy pays roughly $96 to $300 per year. The same therapeutic goal through Strut costs $540 to $1,140 annually.

The IIEF (International Index of Erectile Function) improvements seen with sildenafil are well documented. The original Goldstein et al. trial (N=532) demonstrated that sildenafil 50 mg and 100 mg significantly improved erectile function domain scores versus placebo (mean improvement of 6.0 and 6.8 points, respectively) [6]. These outcomes apply regardless of whether the sildenafil comes from a retail pharmacy or a compounding pharmacy. The molecule is the same.

Strut's compounded ED products sometimes combine sildenafil or tadalafil with other agents like oxytocin or PT-141 (bremelanotide). Bremelanotide received FDA approval in 2019 for hypoactive sexual desire disorder in premenopausal women, not for male ED [7]. Its use in compounded male ED formulations is off-label, and published evidence for this application in men remains limited. A small pilot study (N=20) showed some improvement in erectile response, but no large randomized trial supports routine use [8].

Skincare Products and Their Value Proposition

Strut's dermatology line centers on compounded tretinoin formulas, some containing additional ingredients like niacinamide, azelaic acid, or hydroquinone. Monthly costs range from $30 to $50.

Tretinoin is the gold standard topical retinoid for photoaging. A landmark 48-week randomized trial published in the New England Journal of Medicine (N=251) showed that tretinoin 0.05% cream produced statistically significant improvements in fine wrinkling, coarse wrinkling, and mottled hyperpigmentation compared to vehicle [9]. That study used a simple single-agent formulation.

Generic tretinoin 0.025% cream (45g tube) costs $25 to $70 with a GoodRx coupon and lasts 2 to 3 months. Annual cost: roughly $100 to $420. Strut's skincare subscriptions cost $360 to $600 per year. The premium buys a multi-ingredient compound and the telehealth consultation. Patients who would otherwise see a dermatologist (average copay: $30 to $75 per visit, or $150 to $300 cash pay) may find the bundled model competitive. Those who already have a prescription and fill generics will pay more with Strut.

Is Strut Health Legitimate? Regulatory and Safety Considerations

Strut Health partners with state-licensed compounding pharmacies to fill its prescriptions. This is a legal and regulated process, but it carries distinctions patients should understand.

Compounded medications are not FDA-approved products. The FDA has stated clearly that compounded drugs "are not evaluated for safety and efficacy" in the same manner as commercially manufactured drugs [10]. Section 503A of the Federal Food, Drug, and Cosmetic Act permits compounding pharmacies to prepare individualized prescriptions, but these products do not undergo the same bioequivalence testing as generic drugs approved through the ANDA pathway.

This does not mean compounded drugs are unsafe. It means batch-to-batch consistency, potency verification, and contamination testing depend on the compounding pharmacy's internal quality systems rather than FDA pre-market review. The National Association of Boards of Pharmacy (NABP) accredits compounding pharmacies, and patients can verify accreditation status through the NABP website.

Strut's telehealth consultations use asynchronous provider reviews. A patient completes a health questionnaire, uploads photos if required, and a licensed prescriber reviews the information before authorizing a prescription. The American Medical Association recognizes asynchronous telehealth as an appropriate care modality for low-acuity conditions when proper clinical standards are met [11]. Hair loss, stable ED, and routine skincare fall within this scope.

How Strut Compares to Other Telehealth Platforms

The direct-to-consumer telehealth space for men's health includes Hims, Ro, and several smaller competitors. Pricing across these platforms has compressed over the past three years.

Hims offers generic oral finasteride 1 mg at $23 to $30 per month and generic sildenafil at $2 per dose (sold in packs). Ro prices generic finasteride at $17 to $22 per month and sildenafil at similar per-dose costs. Both platforms also sell compounded products at higher price points comparable to Strut.

Where Strut differentiates is in its emphasis on compounded multi-ingredient formulations rather than standard generics. If a patient wants a simple finasteride or sildenafil prescription filled with an FDA-approved generic, Hims and Ro offer lower entry prices. If a patient specifically wants a compounded topical finasteride-minoxidil combination or a compounded ED formula, Strut's pricing is competitive with comparable offerings from other platforms.

The 2023 Endocrine Society Clinical Practice Guideline on testosterone therapy noted that telehealth prescribing of hormonal and sexual health medications has expanded access but emphasized that "patients should receive the same standard of care regardless of the delivery modality" [12]. Platform choice should hinge on clinical appropriateness, not just price.

Hidden Costs and Subscription Mechanics

Strut operates on auto-renewing monthly subscriptions. The platform does not charge separately for follow-up consultations, which is a genuine cost advantage for patients who would otherwise pay repeat visit fees.

Potential hidden costs to account for:

The subscription auto-renews unless actively cancelled. Patients who forget to cancel before a shipment processes will be charged. Refunds for shipped orders are not guaranteed. Dose adjustments may require a new subscription tier at a different price point. If a compounded medication causes a reaction, switching to a different formula may mean starting a new subscription rather than modifying the existing one.

Shipping is free on most plans, but expedited shipping options, where available, carry additional fees. There is no insurance billing. All Strut purchases are cash-pay, which means they do not count toward a patient's deductible or out-of-pocket maximum. For patients with prescription drug coverage, filling a generic at a retail pharmacy could be cheaper even before accounting for the drug cost itself, simply because it applies toward their annual deductible.

Who Gets the Best Value from Strut Health

Strut Health's pricing makes the most sense for a specific subset of patients.

Patients who want compounded multi-drug topical formulations that are not commercially available as FDA-approved products receive genuine clinical value. A topical finasteride-minoxidil-tretinoin combination in a single vehicle does not exist as an approved product. Strut provides access to that formulation with a built-in prescriber consultation. This matters.

Patients who simply need generic finasteride, generic sildenafil, or generic tretinoin are overpaying. A 2021 analysis in JAMA Internal Medicine found that direct-to-consumer telehealth platforms charged 2 to 5 times more than retail pharmacy prices for equivalent generic medications [13]. Strut fits this pattern for its standard offerings.

The annual cost difference is not trivial. A man using Strut for hair loss ($540/year) and ED ($720/year) pays $1,260 annually. The same therapeutic goals achieved with retail generics (finasteride $60/year + OTC minoxidil $120/year + sildenafil $120/year) would cost $300. The $960 annual difference buys convenience and compounding, not different active molecules.

Patients should also consider that the American Academy of Dermatology guidelines for androgenetic alopecia recommend oral finasteride 1 mg daily as first-line pharmacotherapy, with topical minoxidil as adjunctive therapy [14]. Oral finasteride remains the most evidence-supported option, and it is the cheapest one.

A Cost-Per-Outcome Framework

Evaluating telehealth pricing requires thinking beyond the monthly subscription. The relevant metric is cost per clinically meaningful outcome.

For hair loss, the number needed to treat (NNT) with finasteride 1 mg to prevent visible progression in one additional patient is approximately 5 over 2 years, based on pooled trial data [1]. Every formulation containing finasteride, whether oral generic or compounded topical, works through the same DHT-inhibition mechanism. The outcome depends on the drug reaching the target tissue at sufficient concentration, not on the brand delivering it.

For ED, sildenafil 100 mg produces successful intercourse in approximately 69% of attempts versus 22% for placebo, based on the pooled analysis by Carson et al. (N=6,659) [15]. Again, the molecule determines the outcome. Compounding does not improve the pharmacology.

The cost-per-outcome calculation favors retail generics for single-agent prescriptions. It favors platforms like Strut only when the specific compound formula (multiple active ingredients in one vehicle) provides a genuine convenience or adherence advantage that the patient would not achieve by using separate products.

Patients filling two or three separate prescriptions might benefit from a single daily application. A 2020 adherence study in the British Journal of Dermatology found that topical medication adherence drops by 30% to 40% when regimen complexity increases [16]. If combining finasteride, minoxidil, and tretinoin into one bottle keeps a patient compliant, the premium may be clinically justified.